DifGen Pharmaceuticals, Aveva Drug Delivery Systems Collaborate

DifGen Pharmaceuticals and Aveva Drug Delivery Systems have announced a strategic platform collaboration focused on technology transfer and platform development. Their joint effort targets multi-indication immune restoration therapy, with active IND programs already in place. This partnership with Biostax Corp d/b/a Attune aims to accelerate the development of innovative therapies. The collaboration signifies a move towards synergistic approaches in pharmaceutical research and development, potentially leading to significant advancements in treating various immune-related conditions.